MedTrace Logo

The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria

NCT01551186 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2018-12-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effectiveness of bacteria called Lactobacillus GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in patients on a ventilator.

Conditions

  • Infectious Disease of Digestive Tract

Interventions

DIETARY_SUPPLEMENT

Lactobacillus rhamnosus GG

1 capsule containing 10 billion cells of Lactobacillus rhamnosus GG on a twice-daily basis

Sponsors & Collaborators

Principal Investigators

  • Victoria J Fraser, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01551186 on ClinicalTrials.gov